Mdb capital announces record date and expected timing for initial public offering for invizyne technologies

Record date of july 22, 2024 set for allocation preferences closing and trading expected on nasdaq on or before august 15 addison, texas, july 11, 2024 (globe newswire) -- mdb capital holdings, llc, (nasdaq: mdbh) (“mdb”), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected timeline for the proposed offering for invizyne technologies, inc. in february 2024, invizyne ­– a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life and a subsidiary of mdb capital holdings – filed its ipo registration statement on form s-1 with the u.s. securities and exchange commission ("sec") for the sale of its common stock in a firm commitment public offering. the offering will be for 4,300,000 shares of common stock at a price per share of $4.00, for gross proceeds of $17.2 million.
MDBH Ratings Summary
MDBH Quant Ranking